Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX) closed at $2.50M up 1734400% from its previous closing price of $1.03. In other words, the price has increased by $1734400 from its previous closing price. On the day, 1.73 million shares were traded. BDRX stock price reached its highest trading level at $0.9769 during the session, while it also had its lowest trading level at $0.85.
Ratios:
For a deeper understanding of Biodexa Pharmaceuticals Plc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.75 and its Current Ratio is at 1.75. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ladenburg Thalmann on February 08, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDRX now has a Market Capitalization of 4376371 and an Enterprise Value of 22196543488.
Stock Price History:
The Beta on a monthly basis for BDRX is 1.21, which has changed by -0.96120805 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, BDRX has reached a high of $41.50, while it has fallen to a 52-week low of $0.78. The 50-Day Moving Average of the stock is -33.00%, while the 200-Day Moving Average is calculated to be -78.31%.
Shares Statistics:
For the past three months, BDRX has traded an average of 2.50M shares per day and 5960660 over the past ten days. Shares short for BDRX as of 1748563200 were 366906 with a Short Ratio of 0.15, compared to 1745971200 on 228027. Therefore, it implies a Short% of Shares Outstanding of 366906 and a Short% of Float of 7.26.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.04 and -$0.04 for the fiscal current year, implying an average EPS of -$0.04. EPS for the following year is -$0.01, with 1.0 analysts recommending between -$0.01 and -$0.01.
